# SOLX INC: Form D filings

SOLX INC, a biotechnology company in Waltham, MA, filed 4 Form D notices with the SEC between 2010 and 2015. The latest, on September 11, 2015, reports $2.3 million sold of a $11 million offering to 5 investors.

Find out what SOLX INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20SOLX%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=SOLX%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fsolx-inc-1118997)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20SOLX%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=SOLX%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fsolx-inc-1118997)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts): 1,533 rows, by operating companies, filed since November 1, 2024, $76.65, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/massachusetts
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 230 SECOND AVENUE, SUITE 120, Waltham, MA, 02451
- Phone: (781) 609-2016
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1118997

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sep 11, 2015 | New notice | $10,999,063 | $2,250,000 | $8,749,063 | 5 | Aug 27, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1118997/000111899715000001/0001118997-15-000001-index.htm) |
| Dec 19, 2013 | New notice | $4,824,000 | $2,124,000 | $2,700,000 | 3 | Dec 11, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1118997/000111899713000002/0001118997-13-000002-index.htm) |
| Jan 19, 2012 | New notice | $9,000,000 | $3,250,000 | $5,750,000 | 3 | Jan 6, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1118997/000111899712000001/0001118997-12-000001-index.htm) |
| Oct 27, 2010 | New notice | $7,200,000 | $3,700,000 | $3,500,000 | 6 | Oct 14, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1118997/000111899710000003/0001118997-10-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Jim Largent | Director |  |
| Bosun Hau | Director |  |
| Frank Flautt | Director |  |
| Eric Bednarski | Director |  |
| Kevin McMahon | Executive Officer, Director |  |
| Neil Akhurst | Director |  |

## Other biotechnology companies in Massachusetts that filed recently

- [Zai Lab Ltd](https://specstream.ai/data/form-d/company/zai-lab-ltd-1704292) $249.9 million · Nov 9, 2026
- [AI3 Bio, Inc.](https://specstream.ai/data/form-d/company/ai3-bio-inc-2019875) offering · Nov 4, 2026
- [Tru Singular Health, Inc.](https://specstream.ai/data/form-d/company/tru-singular-health-inc-2158834) $1 million · Oct 30, 2026
- [511 Therapeutics, Inc.](https://specstream.ai/data/form-d/company/511-therapeutics-inc-1946264) $500,000 · Oct 30, 2026
- [Elucid Bioimaging Inc.](https://specstream.ai/data/form-d/company/elucid-bioimaging-inc-1585931) $56.2 million · Oct 27, 2026
- [OrthoIQ, Inc.](https://specstream.ai/data/form-d/company/orthoiq-inc-2154488) $1.1 million · Oct 23, 2026
- [LeanBio Therapeutics, Inc.](https://specstream.ai/data/form-d/company/leanbio-therapeutics-inc-2160802) offering · Oct 22, 2026
- [Quiver Holdings Inc.](https://specstream.ai/data/form-d/company/quiver-holdings-inc-2160800) $3 million · Oct 21, 2026
- [Axelyf, Inc.](https://specstream.ai/data/form-d/company/axelyf-inc-2078406) $2.6 million · Oct 13, 2026
- [BIOVENTRIX, INC.](https://specstream.ai/data/form-d/company/bioventrix-inc-1283259) $1.2 million · Oct 8, 2026
- [Opus KSD, Inc.](https://specstream.ai/data/form-d/company/opus-ksd-inc-1668934) $680,801 · Oct 1, 2026
- [Xact Bio, Inc.](https://specstream.ai/data/form-d/company/xact-bio-inc-2157427) $10 million · Sep 28, 2026
- [Way Biosolutions, Inc.](https://specstream.ai/data/form-d/company/way-biosolutions-inc-2155613) $2 million · Sep 25, 2026
- [AutoIVF, Inc.](https://specstream.ai/data/form-d/company/autoivf-inc-1807161) $1.5 million · Sep 25, 2026
- [Typewriter Therapeutics, Inc.](https://specstream.ai/data/form-d/company/typewriter-therapeutics-inc-2156390) $56.3 million · Sep 21, 2026

[Every Form D from the week of Sep 7, 2015](https://specstream.ai/data/form-d/week/2015-09-07) · [All recent filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what SOLX INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).